TargetCancer Foundation

A bittersweet farewell 💚

After nine years of camaraderie, collaboration, hard work, and friendship, Samantha Sullivan is stepping down from her role at TCF to spend more time with her family.

Samantha was TCF's first hired staff member and quickly became a valued and trustworthy colleague - one who we relied on and whose contributions helped the organization grow during pivotal years.

We know she will be missed by everyone in our community - please join us by leaving a comment to wish her well!

: Celebrating Dr. Deborah Morosini and Steven Young

The TCF-001 TRACK trial is a true team effort. Deborah Morosini, MD, MSW and SARC President and CEO Steven Young are among the original team of experts who helped to develop the TCF-001 TRACK idea and protocol.

"So great to see how far the TRACK study has come, and honored to have helped in my own small way to support TCF's vision during ideation/early study design when I consulted for Jim and TargetCancer Foundation, along with Dr. Deborah Morosini and others. Congratulations to all!" -Steven Young

We are incredibly grateful to Dr. Deborah Morosini and Steven Young for sharing their expertise at this critical phase of study development.

To learn more about TRACK, visit https://targetcancer.org/research/track/

Every cancer patient deserves access to clinical trials, no matter their income or location.

We are proud to sign on to the Senate letter of support for H.R. 3521 / S. 4440, the Clinical Trial Modernization Act, which makes it easier for cancer patients to participate in clinical trials by removing cost barriers and allowing more patients to participate remotely.

To learn more, visit: https://www.fightcancer.org/policy-resources/acs-can-supports-clinical-trial-modernization-act-hr-3521-s-4440